DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients Trial
NCT05977218
Summary
This randomized controlled trial will assess the impact of the FoodSwitch mobile app, which provides interpretive front-of-pack labelling via barcode scanning, in 900 Swedish adults with type 2 diabetes. Participants will be randomized to app + standard advice or standard advice alone. The primary outcome is change in HbA1c at 6 months; secondary outcomes include anthropometrics, quality of life, medication use, hospitalizations, and mortality.
Eligibility
Inclusion criteria: * Age between 18 and 75 years * Self-reported type 2 diabetes with a duration of ≥2 years * Regularly grocery shopping Exclusion criteria: * No access to BankID (a digital identification system commonly used in Sweden) * Failure to complete eligibility screening and run-in periods
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05977218